Kite Pharma, Inc.
KITE
KITE was delisted on the 2nd of October, 2017.
148 hedge funds and large institutions have $1.49B invested in Kite Pharma, Inc. in 2015 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 56 increasing their positions, 31 reducing their positions, and 18 closing their positions.
183% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 18
81% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 31
28% more funds holding
Funds holding: 116 → 148 (+32)
23% more capital invested
Capital invested by funds: $1.21B → $1.49B (+$281M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
8% less call options, than puts
Call options by funds: $20.4M | Put options by funds: $22.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$85M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$57.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$53.2M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$35.7M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$30.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRF
Silver Rock Financial
Los Angeles,
California
|
-$19.9M |
| 2 |
LCP
Lamond Capital Partners
San Francisco,
California
|
-$17.5M |
| 3 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$14.9M |
| 4 |
PC
PointState Capital
New York
|
-$11.1M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$10.5M |
KITE Hedge Fund Activity: Q1 2015 in Review
148 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q1 2015, worth a combined $1.49B — up 23% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new KITE positions and 18 closed out — a net gain of 33 holders — while 56 added to existing stakes and 31 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $85M. The largest seller was Silver Rock Financial, cutting an estimated $19.9M.
- 148 institutional investors held Kite Pharma, Inc. (KITE) as of Q1 2015, up from 116 in Q4 2014.
- Funds reported $1.49B of Kite Pharma, Inc. stock for Q1 2015, up 23% quarter-over-quarter.
- 51 funds opened new Kite Pharma, Inc. positions in Q1 2015 and 18 closed out, a net change of +33 holders.
- The largest Kite Pharma, Inc. buyer in Q1 2015 was Capital Research Global Investors, an estimated $85M added.
- The largest Kite Pharma, Inc. seller in Q1 2015 was Silver Rock Financial, an estimated $19.9M sold.
Based on aggregated 13F filings for Q1 2015.